fluorodeoxyglucose f18 has been researched along with Atrophy in 164 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (4.88) | 18.7374 |
| 1990's | 18 (10.98) | 18.2507 |
| 2000's | 37 (22.56) | 29.6817 |
| 2010's | 78 (47.56) | 24.3611 |
| 2020's | 23 (14.02) | 2.80 |
| Authors | Studies |
|---|---|
| Arias, JF; Benedet, A; Bezgin, G; Bunai, T; Kang, MS; Lussier, F; Matsudaira, T; Obi, T; Ottoy, J; Ouchi, Y; Pascoal, TA; Poltronetti, NM; Rosa-Neto, P; Savard, M; Terada, T; Therriault, J; Tissot, C; Tsukada, H; Wang, YT | 1 |
| Graff-Radford, J; Josephs, KA; Lowe, VJ; Machulda, MM; Pham, NTT; Whitwell, JL | 1 |
| Arivazhagan, A; Asranna, A; Bharath, RD; Iyer, V; Kulanthaivelu, K; Mahadevan, A; Mangalore, S; Mhatre, R; Mundlamuri, R; Nagaraj, C; Raghavendra, K; Rao, MB; Sadashiva, N; Saini, J; Sinha, S; Vivek S, M | 1 |
| Graff-Radford, J; Jack, CR; Josephs, KA; Lowe, VJ; Machulda, MM; Pham, NTT; Shir, D; Whitwell, JL | 1 |
| Cajanus, A; Haapasalo, A; Hartikainen, P; Heikkinen, S; Katisko, K; Krüger, J; Remes, AM; Solje, E; Vanninen, R | 1 |
| Bonanni, L; Da Ronch, C; Fiore, V; Gallucci, M; Grassivaro, F | 1 |
| Gao, L; Lai, H; Li, X; Liang, Z; Qiao, H; Song, Y; Sun, J; Wang, CD; Wu, T; Xu, F; Yan, Z; Yao, T; Ye, C; Zhang, D | 1 |
| Allali, G; Altomare, D; Assal, F; Caprioglio, C; Frisoni, GB; Frölich, L; Garibotto, V; Jessen, F | 1 |
| Appollonio, I; Crivellaro, C; Ferrarese, C; Ferri, F; Impagnatiello, V; Isella, V; Licciardo, D; Mapelli, C; Morzenti, S; Musarra, M; Nastasi, G | 1 |
| Botha, H; Clark, HM; Duffy, JR; Jack, CR; Josephs, KA; Lowe, VJ; Machulda, MM; Schwarz, CG; Senjem, ML; Sintini, I; Strand, EA; Utianski, RL; Whitwell, JL | 1 |
| Bentham, P; Gauthier, S; Kook, K; Miller, S; Schelter, BO; Wischik, CM | 1 |
| Diehl-Schmid, J; Eidelberg, D; Grimmer, T; Jamšek, J; Nguyen, N; Perovnik, M; Rus, T; Šurlan Popović, K; Tang, C; Trošt, M; Vo, A; Yakushev, I | 1 |
| Faruque Reza, M; M Iqbal, S; Normala, I; Siti Aishah, AA | 1 |
| Beg, MF; Heywood, A; Popuri, K; Rosen, H; Stocks, J; Wang, L | 1 |
| Borrie, MJ; Camicioli, R; Chekouo, T; Forkert, ND; Ganesh, A; Hogan, DB; Hsiung, GR; Ismail, Z; Masellis, M; Moorhouse, P; Sajobi, TT; Seitz, DP; Smith, EE; Tartaglia, MC; Wang, M | 1 |
| Carlos, AF; Crum, BA; Graff-Radford, J; Josephs, KA; Lowe, VJ; Machulda, MM; Pham, NTT; Whitwell, JL | 1 |
| Chu, M; Cui, Y; Jiang, D; Jing, D; Liu, L; Liu, Y; Lv, X; Song, W; Wang, Y; Wu, L; Yang, C | 1 |
| Meguro, K; Meguro, M; Takahashi, K; Tashiro, M; Yamaguchi, S | 1 |
| Brendel, M; Chrzanowski, U; Eckenweber, F; Fabisch, KH; Hecher, K; Hochstrasser, T; Kipp, M; Rühling, S; Sacher, C; Schmitz, C | 1 |
| Belho, ES; Dinand, V; Gupta, V; Mahajan, H; Malik, D; Ranjan, R; Seniaray, N; Verma, R | 1 |
| Brucki, SMD; Coutinho, AM; DE Brito, MH; Zampieri, PF | 1 |
| Allegri, R; Barthélemy, NR; Bateman, RJ; Benzinger, TLS; Berman, SB; Buckles, V; Chhatwal, J; Fagan, AM; Farlow, M; Fox, NC; Gabelle, A; Goate, AM; Gordon, BA; Graff-Radford, NR; Hassenstab, J; Ikeuchi, T; Joseph-Mathurin, N; Jucker, M; Karch, CM; Lehmann, S; Levin, J; Li, Y; Martins, RN; Masters, CL; McDade, E; Mendez, PC; Mori, H; Morris, JC; Noble, J; O'Connor, A; Perrin, RJ; Salloway, S; Sato, C; Schofield, PR; Shimada, H; Shoji, M; Suzuki, K; Xiong, C | 1 |
| Bejanin, A; Boeve, BF; Boxer, AL; Cobigo, Y; Dickerson, BC; Gorno-Tempini, M; Iaccarino, L; Jagust, WJ; Knopman, DS; Kornak, J; Marx, G; Miller, BL; Rabinovici, GD; Rosen, HJ; Staffaroni, AM; Tammewar, G | 1 |
| Apostolova, I; Brenner, W; Buchert, R; Gonzalez-Escamilla, G; Grothe, MJ; Hallab, A; Klutmann, S; Lange, C; Özden, C | 1 |
| Ances, BM; Bateman, RJ; Benzinger, TLS; Berman, SB; Brickman, AM; Brooks, WS; Cash, DM; Cash, L; Chhatwal, JP; Cruchaga, C; Dincer, A; Fagan, AM; Farlow, MR; Flores, S; Fox, NC; Fulham, MJ; Ghetti, B; Gordon, BA; Hassenstab, J; Hornbeck, R; Jack, CR; Joseph-Mathurin, N; Jucker, M; Karch, CM; Klunk, W; Koeppe, R; Koudelis, D; Kuffner, T; Levin, J; Luckett, PH; Marcus, D; Masters, CL; McCarthy, J; McCullough, A; McDade, E; Meeker, KL; Mori, H; Morris, JC; Noble, JM; Oh, H; Perrin, RJ; Salloway, S; Schofield, PR; Stern, A; Strain, J; Su, Y; Swisher, L; Vöglein, J; Wang, Q; Weiner, M; Xiong, C | 1 |
| Baker, SL; Edwards, L; Gorno-Tempini, ML; Iaccarino, L; Jagust, WJ; La Joie, R; Landau, SM; Lesman-Segev, OH; Miller, BL; Pham, J; Rabinovici, GD; Rosen, HJ; Soleimani-Meigooni, DN; Strom, A | 1 |
| Nation, DA; Yew, B | 1 |
| Baghel, V; Bal, C; Bansal, A; Kumar, P; Tripathi, M | 1 |
| Delbeuck, X; Fahmi, R; Jaillard, A; Kuchcinski, G; Lopes, R; Maureille, A; Pasquier, F; Petyt, G; Rollin Sillaire, A; Semah, F; Vanhoutte, M | 1 |
| Fellgiebel, A; Fischer, FU; Wolf, D | 1 |
| Annen, J; Cassol, H; Crone, JS; Demertzi, A; Di Perri, C; Frasso, G; Heine, L; Laureys, S; Martial, C; Naccache, L | 1 |
| Camacho, V; Carceller-Sindreu, M; Carrió, I; Fernández-León, A; Gomez-Anson, B; Horta-Barba, A; Kulisevsky, J; Lopez-Mora, DA; Lozano-Martinez, GA; Martínez-Horta, S; Pagonabarraga, J; Perez-Perez, J; Sampedro, F | 1 |
| Benvenutto, A; Ceccaldi, M; Didic, M; Felician, O; Giusiano, B; Guedj, E; Gueriot, C; Guye, M; Koric, L | 1 |
| Drubach, DA; Graff-Radford, J; Jack, CR; Josephs, KA; Lowe, VJ; Machulda, MM; Martin, PR; Reid, RI; Schwarz, CG; Senjem, ML; Sintini, I; Spychalla, AJ; Whitwell, JL | 1 |
| Burns, J; Freeman, C; Kim, SW; Kure Liu, C; Manza, P; Ramirez, V; Shokri-Kojori, E; Tomasi, DG; Volkow, ND; Wang, GJ; Wiers, CE; Zehra, A | 1 |
| Andrews, RD; Matthews, DC; Mosconi, L | 1 |
| Duffy, JR; Gunter, JL; Jack, CR; Josephs, KA; Kantarci, K; Lowe, VJ; Machulda, MM; Murphy, MC; Senjem, ML; Strand, EA; Whitwell, JL; Wille, SM | 1 |
| Benarroch, EE; Drubach, DA; Duffy, JR; Graff-Radford, J | 1 |
| Akdemir, ÜÖ; Kapucu, LÖ; Karakuş, A; Tokçaer, AB | 1 |
| Baker, MC; Duffy, JR; Jack, CR; Josephs, KA; Lowe, V; Machulda, MM; Perkerson, RB; Rademakers, R; Senjem, ML; Strand, EA; Vemuri, P; Whitwell, JL | 1 |
| Budai, A; Fülöp, A; Harsányi, L; Horváth, I; Karlinger, K; Korsós, D; Kovács, N; Máthé, D; Pekli, D; Szigeti, K; Szijártó, A | 1 |
| Bocti, C; Castellano, CA; Cunnane, SC; Fulop, T; Goffaux, P; Lepage, M; Nugent, S; Paquet, N; Whittingstall, K | 1 |
| Ewers, M; Grothe, MJ; Kljajevic, V; Teipel, S | 1 |
| Alexopoulos, P; Drzezga, A; Fellgiebel, A; Förster, S; Gray, K; Grimmer, T; Haller, B; Klupp, E; Kriett, L; Kurz, A; Laskaris, N; Perneczky, R; Yakushev, I | 1 |
| Arbizu, J; Clavero, P; García-Eulate, R; García-García, D; Gasca-Salas, C; González-Redondo, R; Obeso, JA; Rodríguez-Oroz, MC; Zubieta, JL | 1 |
| Boutoleau-Bretonnière, C; Camus, V; Delrieu, J; Desmidt, T; Lebouvier, T; Mullin, E; Payoux, P; Sourdet, S; Vellas, B | 1 |
| Cappa, SF; Cerami, C; Coppi, E; Crespi, C; Della Rosa, PA; Dodich, A; Falini, A; Magnani, G; Marcone, A; Perani, D | 1 |
| Aguera, E; Bernabei, R; Bocchetta, M; Bullock, R; Ceccaldi, M; Dartigues, JF; de Mendonça, A; Didic, M; Eriksdotter, M; Félician, O; Frisoni, GB; Frölich, L; Galluzzi, S; Gertz, HJ; Hallikainen, M; Hasselbalch, SG; Hausner, L; Heuser, I; Jessen, F; Jones, RW; Kehoe, PG; Kurz, A; Lawlor, B; Lleo, A; Martinez-Lage, P; Mecocci, P; Mehrabian, S; Monsch, A; Nobili, F; Nordberg, A; Orgogozo, JM; Pasquier, F; Peters, O; Rikkert, MO; Salmon, E; Sánchez-Castellano, C; Santana, I; Sarazin, M; Traykov, L; Tsolaki, M; Visser, PJ; Wallin, ÅK; Wilcock, G; Wilkinson, D; Wolf, H; Yener, G; Zekry, D | 1 |
| Barkhof, F; Caroli, A; Carter, SF; Choo, IH; Frisoni, GB; Nordberg, A; Ossenkoppele, R; Prestia, A; Scheltens, P; Schöll, M; Teunissen, CE; Van Berckel, B; van der Flier, WM; Wade, SK; Wall, A | 1 |
| Baker, MC; Duffy, JR; Jack, CR; Josephs, KA; Lowe, VJ; Machulda, MM; Perkerson, RB; Rademakers, R; Reid, R; Schwarz, CG; Senjem, ML; Strand, EA; Whitwell, JL | 1 |
| Unschuld, PG | 1 |
| Amaro, E; Grinberg, LT; Grothe, MJ; Heinsen, H; Teipel, SJ | 1 |
| Apostolova, LG; Drubach, DA; Josephs, KA; Lowe, VJ; Machulda, MM; Singh, TD; Whitwell, JL | 1 |
| Endres, D; Lützen, N; Meyer, PT; Perlov, E; Stich, O; Tebartz van Elst, L | 1 |
| Barber, R; Barnett, N; Colloby, SJ; Davison, C; Donaldson, C; Firbank, MJ; Herholz, K; Lloyd, J; O'Brien, JT; Olsen, K; Williams, D | 1 |
| Cai, L; Gao, S; Han, T; Ji, Y; Liu, S; Lu, H; Shi, Z; Wang, X; Wang, XD; Wang, Y; Zhou, Y | 1 |
| Barthel, H; Hoffmann, KT; Marschhauser, A; Obrig, H; Sabri, O; Schroeter, ML; Thöne-Otto, A; Tiepolt, S | 1 |
| Beaunieux, H; Chételat, G; Desgranges, B; Eustache, F; La Joie, R; Pitel, AL; Ritz, L; Segobin, S | 1 |
| Barnes, A; Chan, D; Contarino, VE; D'Incerti, L; Della Rosa, PA; Dickson, JC; Ell, PJ; Fallanca, F; Good, C; Michopoulou, S; Minati, L; Moodley, KK; Pennycook, F; Perani, D; Vanoli, EG | 1 |
| Altmann, A; Greicius, MD; Jagust, WJ; Landau, SM; Ng, B | 1 |
| Grothe, MJ; Teipel, SJ | 1 |
| Grothe, MJ; Teipel, S | 1 |
| Buhour, MS; de La Sayette, V; Desgranges, B; Doidy, F; Eustache, F; Laisney, M; Pitel, AL; Viader, F | 1 |
| Aftab, SA; Grant, C; Lu, Y; Sanan, P; VanDreel, A | 1 |
| Accardo, J; Arnaldi, D; Bossert, I; Buschiazzo, A; Dessi, B; Ferrara, M; Fiz, F; Girtler, N; Mandich, P; Morbelli, S; Nobili, F; Pagani, M; Picco, A; Picori, L; Sambuceti, G | 1 |
| Bartenstein, P; Brendel, M; Därr, S; Delker, A; Förster, S; Kalinowski, E; Levin, J; Pogarell, O; Reinisch, V; Rominger, A | 1 |
| Aisen, PS; Boustani, M; Crane, PK; Farlow, MR; Gao, S; Jack, CR; Jagust, WJ; McDonald, BC; Petersen, RC; Risacher, SL; Saykin, AJ; Tallman, EF; Unverzagt, FW; Weiner, MW; West, JD | 1 |
| Iizuka, T; Kameyama, M | 1 |
| Aisen, PS; Donohue, MC; Insel, PS; Jagust, WJ; Mackin, RS; Mattsson, N; Nosheny, RL; Schöll, M; Tosun, D; Weiner, MW | 1 |
| Barkhof, F; Dols, A; Gossink, F; Kerssens, CJ; Krudop, WA; Möller, C; Peters, A; Pijnenburg, YA; Prins, ND; Scheltens, P; Stek, ML; van Berckel, BN; Vijverberg, EG; Wattjes, MP | 1 |
| Huang, E; Li, W; Risacher, SL; Saykin, AJ | 1 |
| Iwasaki, M; Jin, K; Mugikura, S; Nakasato, N; Sato, S; Suzuki, H; Takahashi, S; Takase, K; Tominaga, T | 1 |
| Betensky, RA; Hanseeuw, BJ; Johnson, KA; Schultz, AP; Sperling, RA | 1 |
| Brendel, M; Danek, A; Huber, M; Huppertz, HJ; Levin, J; Okamura, N; Rominger, A; Schönecker, S; Teipel, S; Vollmar, C | 1 |
| Bischof, GN; Dronse, J; Drzezga, A; Faber, J; Fink, GR; Fliessbach, K; Hammes, J; Jessen, F; Klockgether, T; Kuhnert, G; Kukolja, J; Neumaier, B; Onur, OA; van Eimeren, T; von Reutern, B | 1 |
| Baldinelli, S; Cafazzo, V; Fabi, K; Fringuelli, F; Gainotti, G; Luzzi, S; Provinciali, L; Ranaldi, V; Reverberi, C; Silvestrini, M | 1 |
| Blümcke, I; Hildebrandt, M; Holthausen, H; Karlmeier, A; Kolodziejczyk, D; Krsek, P; Pauli, E; Pieper, T; Winkler, P | 1 |
| Baron, JC; Chételat, G; de la Sayette, V; Desgranges, B; Eustache, F; Landeau, B; Mézenge, F; Viader, F; Villain, N | 1 |
| Fong, D; Wong, ST; Yuen, SC | 1 |
| Aresi, A; Bizzi, A; Giovagnoli, AR; Gobbo, C; Reati, F; Riva, A | 1 |
| Bertran, F; Clochon, P; Denise, P; Desgranges, B; Eustache, F; Foret, J; Mézenge, F; Yaouhi, K | 1 |
| Almubarak, S; Gan, YC; Goddard, K; Hendson, G; Hukin, J; Nadel, H; Poskitt, K; Steinbok, P | 1 |
| Baron, JC; Chételat, G; Desgranges, B; Eustache, F; Villain, N | 1 |
| Hattori, N; Ishii, K; Kambe, T; Motoi, Y | 1 |
| Bonetti, M; Caroli, A; Cotelli, M; Frisoni, GB; Geroldi, C; Lorenzi, M; Nobili, F; Paghera, B | 1 |
| Hoffmann, S; Jurkat-Rott, K; Kassubek, J; Lehmann-Horn, F; Lerche, H; Mottaghy, FM; Reske, SN; Roebling, R; Rosenbohm, A; Steinbach, P; Walter, H; Weber, YG; Wolf, M | 1 |
| Boeve, BF; Frank, AR; Jack, CR; Kantarci, K; Kemp, BJ; Knopman, DS; Lowe, VJ; Petersen, RC; Senjem, ML; Shiung, MM; Weigand, SD; Wiste, HJ | 1 |
| Castelnovo, G; Collombier, L; Labauge, P; Renard, D | 1 |
| Cirillo, M; Giordano, A; Marcuccio, L; Russo, A; Tedeschi, G; Tessitore, A | 1 |
| Fujita, Y; Fukuyama, H; Ihara, M; Ito, H; Kalaria, RN; Maki, T; Miyakawa, T; Nishio, K; Oishi, N; Takahashi, R; Tomimoto, H; Yamasaki, N | 1 |
| Barkhof, F; Boverhoff, J; Herholz, K; Lammertsma, AA; Raijmakers, PG; Scheltens, P; Tolboom, N; van Berckel, BN; van der Flier, WM; Wattjes, MP; Yaqub, M | 1 |
| Bibb, JA; Cui, H; Drerup, JM; Goldberg, MS; Hayashi, K; Long, MA; Lutter, M; Marvin, M; Mettlach, GL; Sun, X | 1 |
| Ikeda, T; Ikeda, Y; Iwasa, K; Mastunari, I; Morinaga, A; Noguchi-Shinohara, M; Ono, K; Samuraki, M; Shima, K; Yamada, M; Yanase, D; Yoshita, M | 1 |
| Aalto, S; Haaparanta, M; Jokinen, P; Någren, K; Parkkola, R; Rinne, JO; Rokka, J; Röyttä, M; Savisto, N; Scheinin, N | 1 |
| Hajak, G; Hirschberger, B; Ibach, B; Klünemann, H; Männer, P; Marienhagen, J; Poljansky, S | 1 |
| Acosta-Cabronero, J; Fryer, TD; Hodges, JR; Nestor, PJ; Patterson, K; Pengas, G; Williams, GB | 1 |
| Heinz, TK; Margareta, H; Peter, F; Silvia, W; Susanne, J; Thomas, L; Wolfgang, K | 1 |
| Alberici, A; Archetti, S; Bonvicini, C; Borroni, B; Gennarelli, M; Lupi, A; Padovani, A; Pilotto, A | 1 |
| Ataka, S; Miki, T; Mori, H; Shimada, H; Takechi, H; Tomiyama, T | 1 |
| Chen, WP; Matsuda, H; Matsunari, I; Miyazaki, Y; Noguchi-Shinohara, M; Ono, K; Samuraki, M; Shima, K; Takeda, N; Yamada, M; Yanase, D; Yoshita, M | 1 |
| Chiacchio, L; Errichiello, L; Fragassi, NA; Pappatà, S; Striano, P; Striano, S; Tedeschi, MR | 1 |
| Bredella, MA; Cypess, AM; Fitch, K; Grinspoon, S; Lim, R; Sass, CA; Stavrou, E; Torriani, M | 1 |
| Ahnert-Hilger, G; Buchert, R; Dalmau, J; Gomez, A; Harms, L; Höltje, M; Klingbeil, C; Kohler, S; Kopp, U; Maier, N; Probst, C; Prüss, H; Schmitz, D; Schwab, JM; Stoecker, W; Terborg, C; Wandinger, KP | 1 |
| Binns, D; Cardamone, L; Hicks, RJ; Jones, N; Jupp, B; O'Brien, TJ; Rees, S; Williams, J | 1 |
| Almkvist, O; Bogdanovic, N; Ferreira, D; Graff, C; Långström, B; Nordberg, A; Schöll, M; Thordardottir, S; Wall, A | 1 |
| Arruga, J; Campdelacreu, J; Gascon-Bayarri, J; Juncadella, M; Muñoz, S; Reñé, R; Rico, I | 1 |
| Bares, R; Bender, B; Ernemann, U; Horger, M; Mänz, C; Reimold, M | 1 |
| Basu, S; Chouhan, A | 1 |
| Bihl, H; Büll, U; Drzezga, A; Gratz, KF; Grünwald, F; Henkel, K; Hertel, A; Poser, S; Schröter, A; Spitz, J; Tschampa, HJ; Zerr, I | 1 |
| Alexander, GE; Hampel, H; Möller, HJ; Pogarell, O; Rapoport, SI; Teipel, SJ | 1 |
| Ghaemi, M; Heiss, WD; Hilker, R; Rudolf, J; Sobesky, J | 1 |
| Babb, T; Bingaman, W; Diehl, B; LaPresto, E; Lüders, HO; Najm, I; Raja, S; Rona, S; Ruggieri, P; Ying, Z | 1 |
| Capovilla, G; Chiapparini, L; Ciceri, E; Dalla Bernardina, B; Erbetta, A; Farina, L; Freri, E; Fusco, L; Giordano, L; Gobbi, G; Granata, T; Ragona, F; Savoiardo, M; Spreafico, R; Tassi, L; Viri, M | 1 |
| Baron, JC; Berkouk, K; Chetelat, G; de la Sayette, V; Desgranges, B; Dupuy, B; Eustache, F; Hannequin, D; Lalevée, C; Landeau, B; Le Doze, F; Viader, F | 1 |
| Caine, D; Clarke, J; Fryer, TD; Hodges, JR; Nestor, PJ | 1 |
| Lee, AG; Martin, CO | 1 |
| Cole, AJ; Cosgrove, GR; Doherty, CP; Dooling, E; Fischman, A; Grant, PE; Hoch, DB; White, TH | 1 |
| Benito, C; Molina, V; Palomo, T; Sanz, J; Sarramea, F | 1 |
| Els, T; Huppertz, HJ; Juengling, FD; Kassubek, J; Krause, T | 1 |
| Chen, W; Fujikawa, A; Matsuda, H; Matsunari, I; Nishimura, S; Yajima, K; Yamada, M; Yanase, D | 1 |
| Daniels, W; Harvey, BH; Stein, DJ; Uys, J | 1 |
| Berman, SM; Brody, AL; Geaga, JA; Hayashi, KM; Hong, MS; Ling, W; London, ED; Mandelkern, MA; Monterosso, J; Rawson, RA; Simon, SL; Thompson, PM; Voytek, B | 1 |
| Bartenstein, P; Bokde, AL; Born, C; Dong, W; Drzezga, A; Hampel, H; Leinsinger, G; Moeller, HJ; Schwaiger, M; Teipel, SJ; Thissen, J | 1 |
| Cannella, M; Ciarmiello, A; Frati, L; Lastoria, S; Rubinsztein, DC; Simonelli, M; Squitieri, F | 1 |
| Briest, S; Kluge, R; Scheid, R; Voltz, R; von Cramon, DY | 1 |
| Haginoya, K; Higano, S; Iinuma, K; Ishitobi, M; Kitamura, T; Nara, T; Onuma, A; Togashi, N; Wakusawa, K; Yokoyama, H | 1 |
| Comans, EF; Hadithi, M; Mallant, M; Mulder, CJ; Oudejans, J; van Waesberghe, JH | 1 |
| Halmagyi, M; Savage, G; Williams, MA | 1 |
| Buchsbaum, MS; Flory, J; Goodman, M; Hazlett, EA; Haznedar, MM; Koenigsberg, HW; Mitelman, SA; New, AS; Newmark, R; Siever, LJ; Trisdorfer, R | 1 |
| Antozzi, C; Bellomo, R; Chiapparini, L; Granata, T; Michelucci, R; Pincherle, A; Rubboli, G; Simone, I; Spreafico, R; Villani, F | 1 |
| Neumann, J; Raczka, K; Schroeter, ML; Yves von Cramon, D | 1 |
| Kuhl, DE; Markham, CH; Metter, EJ; Phelps, ME; Riege, WH; Winter, J | 1 |
| Baulac, M; Frouin, V; Hasboun, D; Laplane, D; Leroy-Willig, A; Mangin, JF; Papageorgiou, S; Philippon, J; Samson, Y; Semah, F | 1 |
| Bateman, JB; Chugani, HT; Philippart, M | 1 |
| Bressi, S; Caraceni, T; Cortelli, P; Fazio, F; Gentrini, S; Grassi, F; Perani, D; Savoiardo, M; Testa, D | 1 |
| Chaly, T; Dhawan, V; Eidelberg, D; Fahn, S; Giladi, N; Ishikawa, T; Przedborski, S; Spetsieris, P; Takikawa, S | 1 |
| Akashi, Y; Fukumura, T; Goto, I; Hosokawa, S; Ichiya, Y; Kato, M; Kuwabara, Y; Masuda, K; Otsuka, M; Yoshida, T | 1 |
| Alavi, A; Berlin, JA; Newberg, AB; Souder, E | 1 |
| Cantos, EL; Cestaro, VL; Dhawan, AP; Hitzemann, RJ; Levy, AV; Roque, CT; Volkow, ND; Wang, GJ | 1 |
| Dhawan, V; Eidelberg, D; Fahn, S; Giladi, N; Goldman, S; Hildebrand, J; Przedborski, S; Takikawa, S | 1 |
| Adams, KM; Berent, S; Brunberg, JA; Dede, D; Gilman, S; Kluin, KJ; Koeppe, RA; Kroll, PD | 1 |
| Fujiwara, T; Ido, T; Itoh, M; Itoyama, Y; Iwata, R; Kimura, I; Nagasawa, H; Nomura, H; Saito, H; Tanji, H; Tuji, S | 1 |
| Berkovic, SF; Berlangieri, SU; Cook, MJ; Kilpatrick, C; Morris, K; Newton, MR; O'Brien, TJ | 1 |
| Bergman, J; Haaparanta, M; Härkönen, R; Jääskeläinen, S; Kälviäinen, R; Knuuti, J; Lamusuo, S; Mervaala, E; Nousiainen, U; Rinne, JK; Rinne, JO; Ruotsalainen, U; Ruottinen, HM; Solin, O; Vapalahti, M; Ylinen, A | 1 |
| Csornai, M; Emri, M; Esik, O; Gödény, M; Kásler, M; Trón, L | 1 |
| Cross, DJ; Foster, NL; Henry, TR; Kuhl, DE; Minoshima, S | 1 |
| Brooks, WS; Creasey, H; Fulham, MJ; Halliday, GM; Kwok, JB; Morris, JG; Schofield, PR; Stanford, PM; Storey, CE | 1 |
| Adam, C; Baulac, M; Clémenceau, S; Dupont, S; Samson, Y; Semah, F | 1 |
| Gustin, S; Halsband, U; Heinks, T; Hüll, M; Juengling, FD; Kassubek, J; Schumann, G | 1 |
| Cross, DJ; Drzezga, A; Ficaro, EP; Ishii, K; Kuhl, DE; Minoshima, S; Schwaiger, M; Willoch, F | 1 |
| Al-Sugair, AA; Coleman, RE; Crain, BJ; Fiorella, DJ; Provenzale, JM | 1 |
| Aassar, OS; Barbaro, N; Ende, G; Hawkins, RA; Klein, G; Knowlton, RC; Laxer, KD; Sawrie, S; Soohoo, K; Wong, S | 1 |
| Goldman, S; Michotte, A; Tugendhaft, P; Zegers de Beyl, D | 1 |
| Ito, K; Kato, T; Kume, A; Sakuma, S; Shiratori, M; Tadokoro, M; Takahashi, A | 1 |
| Benson, DF; Hanson, WR; Jackson, CA; Kempler, D; Metter, EJ; Riege, WH | 1 |
| Baser, S; Brooks, RA; Brown, RT; Curras, MT; Di Chiro, G; Dubinsky, RM; Fulham, MJ; Hallett, M; Polinsky, RJ | 1 |
| Bromberg, MB; Gebarski, SS; Gilman, S; Junck, L; McLean, MJ | 1 |
| Haupt, WF; Holthoff, V; Nowak, A | 1 |
| Cutler, NR; Duara, R; Grady, C; Haxby, J; Heston, L; Larson, S; Moore, A; Rapoport, SI; Schlageter, N; Sundaram, M | 1 |
| Harrop, R; Kamo, H; Li, DK; Martin, WR; McGeer, EG; McGeer, PL; Pate, BD | 1 |
| Alavi, A; Bais, S; Chawluk, JB; Dann, R; Hurtig, HI; Kushner, MJ; Reivich, M; Zimmerman, RA | 1 |
| Berg, GW; Carson, R; Creasey, H; Duara, R; Horwitz, B; Rapoport, SI; Schlageter, NL | 1 |
| Adam, MJ; Ammann, W; Beattie, BL; Calne, DB; Harrop, R; Kamo, H; Li, DK; McGeer, EG; McGeer, PL; Tuokko, H | 1 |
| Kling, AS; Kuhl, DE; Metter, EJ; Riege, WH | 1 |
6 review(s) available for fluorodeoxyglucose f18 and Atrophy
| Article | Year |
|---|---|
[Possibilities of modern imaging technologies in early diagnosis of Alzheimer disease].
Topics: Aged; Alzheimer Disease; Atrophy; Brain; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Plaque, Amyloid; Positron-Emission Tomography; Switzerland | 2015 |
FDG-PET Contributions to the Pathophysiology of Memory Impairment.
Topics: Aging; Alcoholism; Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Brain; Female; Fluorodeoxyglucose F18; Glucose; Gray Matter; Humans; Image Processing, Computer-Assisted; Memory Disorders; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Signal Processing, Computer-Assisted | 2015 |
[Imaging diagnosis of Alzheimer's disease].
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Atrophy; Brain; Carbon Radioisotopes; Cerebral Cortex; Diagnostic Imaging; Diffusion Tensor Imaging; Dominance, Cerebral; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Nerve Net; Organ Size; Oxygen; Positron-Emission Tomography; Radiographic Image Enhancement; Regional Blood Flow; Thiazoles | 2012 |
Towards a nosology for frontotemporal lobar degenerations-a meta-analysis involving 267 subjects.
Topics: Aged; Algorithms; Atrophy; Brain Mapping; Dementia; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Radiation myelopathy with partial functional recovery: PET evidence of long-term increased metabolic activity of the spinal cord.
Topics: Adult; Atrophy; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Node Excision; Magnetic Resonance Imaging; Methionine; Neoplasm Staging; Oxygen Radioisotopes; Radiopharmaceuticals; Radiotherapy; Spinal Cord; Thyroid Neoplasms; Tomography, Emission-Computed | 1999 |
Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Atrophy; Cerebellar Cortex; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Magnetic Resonance Spectroscopy; Male; Middle Aged; Oxygen; Psychological Tests; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed; Water | 1986 |
6 trial(s) available for fluorodeoxyglucose f18 and Atrophy
| Article | Year |
|---|---|
Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate.
Topics: Activities of Daily Living; Alzheimer Disease; Atrophy; Fluorodeoxyglucose F18; Humans; Mesylates | 2022 |
Brain 18F-FDG PET imaging in the differential diagnosis of parkinsonism.
Topics: Adult; Aged; Atrophy; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinsonian Disorders; Positron-Emission Tomography | 2014 |
Effects of age on the glucose metabolic changes in mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Atrophy; Biomarkers; Blood Glucose; Cognition Disorders; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parietal Lobe; Positron-Emission Tomography; Reproducibility of Results; Temporal Lobe | 2010 |
Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.
Topics: Adult; Atrophy; Brain; Cohort Studies; Female; Fluorodeoxyglucose F18; Glucose Metabolism Disorders; Humans; Huntington Disease; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Fibers, Myelinated; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity | 2006 |
Striatal 18F-dopa uptake and brain glucose metabolism by PET in patients with syndrome of progressive ataxia.
Topics: Adult; Aged; Ataxia; Atrophy; Brain Chemistry; Brain Stem; Cerebellum; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neostriatum; Olivopontocerebellar Atrophies; Tomography, Emission-Computed | 1994 |
Comparison of [18F]FDG-PET, [99mTc]-HMPAO-SPECT, and [123I]-iomazenil-SPECT in localising the epileptogenic cortex.
Topics: Adolescent; Adult; Atrophy; Cerebral Cortex; Electroencephalography; Epilepsy; Female; Flumazenil; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
152 other study(ies) available for fluorodeoxyglucose f18 and Atrophy
| Article | Year |
|---|---|
Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloidosis; Aniline Compounds; Atrophy; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography | 2022 |
Medial Temporal Atrophy in Posterior Cortical Atrophy and Its Relationship to the Cingulate Island Sign.
Topics: Alzheimer Disease; Atrophy; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Positron-Emission Tomography | 2022 |
Rasmussen's encephalitis: Imaging spectrum on simultaneous FDG-PET and MRI imaging correlation.
Topics: Adult; Atrophy; Child; Encephalitis; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neurodegenerative Diseases | 2022 |
Posterior cortical atrophy: Primary occipital variant.
Topics: Alzheimer Disease; Atrophy; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2022 |
Brainstem atrophy is linked to extrapyramidal symptoms in frontotemporal dementia.
Topics: Atrophy; Basal Ganglia Diseases; Brain Stem; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging; Retrospective Studies | 2022 |
"Occipital Pole" Sign on 18 F-FDG PET for Dementia With Lewy Bodies and Posterior Cortical Atrophy : Evidence From the Treviso Dementia (TREDEM) Registry.
Topics: Alzheimer Disease; Atrophy; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Occipital Lobe; Positron-Emission Tomography; Registries | 2022 |
Clinical and Preclinical Neuroimaging Changes in Spinocerebellar Ataxia Type 12: A Study of Three Chinese Pedigrees.
Topics: Atrophy; China; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuroimaging; Pedigree; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Spinocerebellar Ataxias | 2022 |
The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Biomarkers; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Peptide Fragments; Positron-Emission Tomography; tau Proteins | 2022 |
Clinical and metabolic imaging features of late-onset and early-onset posterior cortical atrophy.
Topics: Aged; Alzheimer Disease; Atrophy; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography | 2022 |
Functional connectivity to the premotor cortex maps onto longitudinal brain neurodegeneration in progressive apraxia of speech.
Topics: Aphasia, Primary Progressive; Apraxias; Atrophy; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Motor Cortex; Primary Progressive Nonfluent Aphasia; Speech | 2022 |
Disease specific and nonspecific metabolic brain networks in behavioral variant of frontotemporal dementia.
Topics: Alzheimer Disease; Atrophy; Brain; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging | 2023 |
Mapping cerebral atrophy and hypometabolism on
Topics: Alzheimer Disease; Atrophy; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography | 2023 |
Longitudinal Spatial Relationships Between Atrophy and Hypometabolism Across the Alzheimer's Disease Continuum.
Topics: Alzheimer Disease; Atrophy; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuroimaging; Positron-Emission Tomography; tau Proteins | 2023 |
Expert elicitation of risk factors for progression to dementia in individuals with mild cognitive impairment.
Topics: Alzheimer Disease; Atrophy; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans | 2023 |
Antiphospholipid syndrome mimicking posterior cortical atrophy and the "railroad track" sign on brain fluorodeoxyglucose-positron emission tomography.
Topics: Antiphospholipid Syndrome; Atrophy; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Railroads | 2023 |
Neurofunctional Correlates of Activities of Daily Living in Patients with Posterior Cortical Atrophy.
Topics: Activities of Daily Living; Alzheimer Disease; Atrophy; Cerebral Cortex; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2023 |
Alzheimer's deterioration in intellectual and neurobiological staging supports the retrogenesis model: a double dissociation between verbal/non-verbal judgments and the left/right parieto-temporal glucose metabolism. A retrospective data analysis from the
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Brain; Data Analysis; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Judgment; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Retrospective Studies; Stanford-Binet Test; Temporal Lobe | 2020 |
Stereological Investigation of Regional Brain Volumes after Acute and Chronic Cuprizone-Induced Demyelination.
Topics: Animals; Atrophy; Brain; Chelating Agents; Cuprizone; Fluorodeoxyglucose F18; Male; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
Metabolic imaging patterns in posterior cortical atrophy and Lewy body dementia.
Topics: Atrophy; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
Brain [18F]FDG PET-CT imaging in posterior cortical atrophy.
Topics: Aged; Atrophy; Cerebral Cortex; Fluorodeoxyglucose F18; Humans; Male; Neurodegenerative Diseases; Neuroimaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Amyloid; Atrophy; Brain; Cognition; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Inheritance Patterns; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Phosphorylation; Plaque, Amyloid; Solubility; tau Proteins | 2020 |
Longitudinal structural and metabolic changes in frontotemporal dementia.
Topics: Aged; Atrophy; Cerebral Cortex; Disease Progression; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Impairment of Everyday Spatial Navigation Abilities in Mild Cognitive Impairment Is Weakly Associated with Reduced Grey Matter Volume in the Medial Part of the Entorhinal Cortex.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Atrophy; Cognitive Dysfunction; Entorhinal Cortex; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals; Spatial Navigation | 2020 |
Modeling autosomal dominant Alzheimer's disease with machine learning.
Topics: Adult; Alzheimer Disease; Amyloid; Aniline Compounds; Atrophy; Female; Fluorodeoxyglucose F18; Humans; Machine Learning; Magnetic Resonance Imaging; Male; Mutation; Positron-Emission Tomography; Thiazoles | 2021 |
Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid; Apolipoprotein E4; Atrophy; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; tau Proteins | 2022 |
Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Atrophy; Blood Pressure; Brain; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Neurons; Neuropsychological Tests; Positron-Emission Tomography; Spin Labels; Vascular Resistance; White Matter | 2017 |
F-18 FDG and F-18 Tau PET in posterior cortical atrophy.
Topics: Alzheimer Disease; Atrophy; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; tau Proteins | 2017 |
Topics: Alzheimer Disease; Atrophy; Cerebral Cortex; Cognition; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Male; Middle Aged; Neuropsychological Tests; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Diaschisis-Like Association of Hippocampal Atrophy and Posterior Cingulate Cortex Hypometabolism in Cognitively Normal Elderly Depends on Impaired Integrity of Parahippocampal Cingulum Fibers.
Topics: Aged; Aged, 80 and over; Aging; Atrophy; Brain Mapping; Female; Fluorodeoxyglucose F18; Glucose; Gray Matter; Gyrus Cinguli; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Parahippocampal Gyrus; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis | 2017 |
Regional brain volumetry and brain function in severely brain-injured patients.
Topics: Adult; Analysis of Variance; Atrophy; Brain; Brain Injuries; Female; Fluorodeoxyglucose F18; Glasgow Outcome Scale; Gray Matter; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Persistent Vegetative State; Positron-Emission Tomography; Retrospective Studies; ROC Curve; White Matter; Young Adult | 2018 |
Structural and metabolic brain correlates of apathy in Huntington's disease.
Topics: Aged; Apathy; Atrophy; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Huntington Disease; Imaging, Three-Dimensional; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Tomography Scanners, X-Ray Computed | 2018 |
Imaging Biomarkers of Neurodegeneration in Alzheimer's Disease: Distinct Contributions of Cortical MRI Atrophy and FDG-PET Hypometabolism.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Biomarkers; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Degeneration; Peptide Fragments; Positron-Emission Tomography; tau Proteins | 2018 |
Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anisotropy; Aphasia, Primary Progressive; Atrophy; Brain Mapping; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Tauopathies; White Matter | 2019 |
Association Between Reduced Brain Glucose Metabolism and Cortical Thickness in Alcoholics: Evidence of Neurotoxicity.
Topics: Alcoholism; Atrophy; Case-Control Studies; Cerebral Cortex; Ethanol; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Neurotoxicity Syndromes; Positron-Emission Tomography | 2019 |
Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidosis, Familial; Atrophy; Blood Glucose; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Reference Values | 2013 |
Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia.
Topics: Aged; Amyloid beta-Peptides; Aniline Compounds; Aphasia, Primary Progressive; Atrophy; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Intracranial Hemorrhages; Male; Middle Aged; Nerve Fibers, Myelinated; Neuroimaging; Neuropsychological Tests; Occipital Lobe; Radionuclide Imaging; Thiazoles | 2013 |
Fluorodeoxyglucose F18 positron emission tomography in a case of slowly progressive pure alexia.
Topics: Aged; Alexia, Pure; Atrophy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuropsychological Tests; Occipital Lobe; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Progranulin-associated PiB-negative logopenic primary progressive aphasia.
Topics: Age Factors; Aged; Amyloid beta-Peptides; Aniline Compounds; Aphasia, Primary Progressive; Apolipoproteins E; Atrophy; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Intercellular Signaling Peptides and Proteins; Language Tests; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Mutation; Neuropsychological Tests; Parietal Lobe; Positron-Emission Tomography; Progranulins; Temporal Lobe; Thiazoles; Tomography, X-Ray Computed | 2014 |
Demonstration of metabolic and cellular effects of portal vein ligation using multi-modal PET/MRI measurements in healthy rat liver.
Topics: Animals; Atrophy; Fluorodeoxyglucose F18; Glycogen; Health; Heart Ventricles; Hypertrophy; Ligation; Liver; Magnetic Resonance Imaging; Male; Multimodal Imaging; Portal Vein; Positron-Emission Tomography; Radioactive Tracers; Rats; Rats, Wistar; Time Factors; Tissue Distribution | 2014 |
Glucose hypometabolism is highly localized, but lower cortical thickness and brain atrophy are widespread in cognitively normal older adults.
Topics: Adult; Aged; Aging; Antihypertensive Agents; Atrophy; Blood Glucose; Brain; Brain Chemistry; Cerebral Cortex; Cognition; Executive Function; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Kinetics; Magnetic Resonance Imaging; Male; Memory, Long-Term; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2014 |
Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidogenic Proteins; Atrophy; Cognitive Dysfunction; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Synapses | 2014 |
Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Apolipoproteins E; Atrophy; Biomarkers; Chi-Square Distribution; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography; tau Proteins | 2014 |
Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
Topics: Aged; Aged, 80 and over; Atrophy; Cerebral Cortex; Cognitive Dysfunction; Cross-Sectional Studies; Dementia; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index | 2014 |
Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study.
Topics: Aged; Alzheimer Disease; Apathy; Atrophy; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography | 2015 |
Brain changes within the visuo-spatial attentional network in posterior cortical atrophy.
Topics: Aged; Atrophy; Attention Deficit Disorder with Hyperactivity; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Perceptual Disorders; Photic Stimulation; Positron-Emission Tomography; Space Perception | 2015 |
The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Biomarkers; Brain; Cognitive Dysfunction; Europe; Fluorodeoxyglucose F18; Internet; Magnetic Resonance Imaging; Peptide Fragments; Positron-Emission Tomography; Practice Patterns, Physicians'; Radiopharmaceuticals; Surveys and Questionnaires; tau Proteins | 2015 |
Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Atrophy; Biomarkers; Disease Progression; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; tau Proteins | 2015 |
Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aphasia, Primary Progressive; Atrophy; Biomarkers; Brain Mapping; Cerebral Cortex; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography | 2015 |
Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment.
Topics: Aged; Amyloid; Atrophy; Brain; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Neuropsychological Tests; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Signal Processing, Computer-Assisted | 2016 |
Clinical, FDG and amyloid PET imaging in posterior cortical atrophy.
Topics: Aged; Amyloid; Aniline Compounds; Atrophy; Brain; Brain Mapping; Carbon Isotopes; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurologic Examination; Positron-Emission Tomography; Thiazoles; Tomography, X-Ray Computed | 2015 |
Case report: low-titre anti-Yo reactivity in a female patient with psychotic syndrome and frontoparieto-cerebellar atrophy.
Topics: Atrophy; Cerebellum; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Magnetic Resonance Imaging; Nerve Tissue Proteins; Paraneoplastic Syndromes, Nervous System; Parietal Lobe; Positron-Emission Tomography; Psychoses, Substance-Induced; Radiopharmaceuticals; Young Adult | 2015 |
An evidence-based algorithm for the utility of FDG-PET for diagnosing Alzheimer's disease according to presence of medial temporal lobe atrophy.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Evidence-Based Practice; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Temporal Lobe | 2016 |
A Pilot Study on Clinical and Neuroimaging Characteristics of Chinese Posterior Cortical Atrophy: Comparison with Typical Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Occipital Lobe; Pilot Projects; Positron-Emission Tomography | 2015 |
Dissociation of amyloid biomarkers in PET and CSF in Alzheimer's disease: a case report.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Biomarkers; Brain; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins | 2015 |
Simultaneous PET-MRI Studies of the Concordance of Atrophy and Hypometabolism in Syndromic Variants of Alzheimer's Disease and Frontotemporal Dementia: An Extended Case Series.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Psychiatric Status Rating Scales; Reproducibility of Results | 2015 |
Regional brain hypometabolism is unrelated to regional amyloid plaque burden.
Topics: Aged; Aniline Compounds; Atrophy; Brain; Case-Control Studies; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Plaque, Amyloid; Positron-Emission Tomography | 2015 |
Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer's disease correspond to dissociable functional brain networks.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Atrophy; Brain; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Mental Status Schedule; Metabolic Diseases; Middle Aged; Models, Neurological; Neural Pathways; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer's disease?
Topics: Aged; Aging; Alzheimer Disease; Atrophy; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Gray Matter; Gyrus Cinguli; Hippocampus; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography | 2016 |
Pathophysiology of the behavioral variant of frontotemporal lobar degeneration: A study combining MRI and FDG-PET.
Topics: Aged; Atrophy; Biological Variation, Individual; Brain; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |
Fusion FDG-PET/MRI Evidence to Support Diagnosis of Frontotemporal Dementia-Related Primary Progressive Aphasia.
Topics: Aphasia, Primary Progressive; Atrophy; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Temporal Lobe | 2016 |
Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD.
Topics: Aged; Atrophy; Brain; Brain Mapping; Case-Control Studies; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography | 2016 |
Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Atrophy; Brain; Databases as Topic; Depression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales | 2016 |
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.
Topics: Aged; Aged, 80 and over; Apolipoprotein E4; Atrophy; Brain; Cholinergic Antagonists; Cognition Disorders; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Memory Disorders; Neuropsychological Tests; Positron-Emission Tomography; Proportional Hazards Models | 2016 |
Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Atrophy; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Temporal Lobe; Tomography, Emission-Computed, Single-Photon | 2016 |
Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology.
Topics: Aged; Amyloid beta-Peptides; Aniline Compounds; Atrophy; Biomarkers; Brain; Cognition; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status Schedule; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis | 2016 |
Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes.
Topics: Age of Onset; Aged; Atrophy; Brain; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Frontotemporal Dementia; Humans; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Neuroimaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2016 |
Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort.
Topics: Aged; Atrophy; Brain; Cognitive Dysfunction; Corpus Striatum; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Frontal Lobe; Gray Matter; Humans; Male; Positron-Emission Tomography; Sensorimotor Cortex; White Matter | 2016 |
T2 relaxometry improves detection of non-sclerotic epileptogenic hippocampus.
Topics: Adolescent; Adult; Atrophy; Drug Resistant Epilepsy; Electrocorticography; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sclerosis; Young Adult | 2016 |
Decreased hippocampal metabolism in high-amyloid mild cognitive impairment.
Topics: Aged; Amyloid; Aniline Compounds; Atrophy; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Thiazoles | 2016 |
Applied multimodal diagnostics in a case of presenile dementia.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Biomarkers; Early Diagnosis; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Middle Aged; Neuroimaging; Parietal Lobe; Peptide Fragments; Positron-Emission Tomography; tau Proteins | 2016 |
In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Brain; Carbolines; Cognition Disorders; Corticomedial Nuclear Complex; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Language Disorders; Male; Neuropsychological Tests; Positron-Emission Tomography; tau Proteins | 2017 |
Famous faces and voices: Differential profiles in early right and left semantic dementia and in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Association; Atrophy; Brain; Discrimination, Psychological; Facial Recognition; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Functional Laterality; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Recognition, Psychology; Speech Perception | 2017 |
Different presurgical characteristics and seizure outcomes in children with focal cortical dysplasia type I or II.
Topics: Age of Onset; Antibodies, Monoclonal; Atrophy; Child; Electroencephalography; Female; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Hippocampus; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Malformations of Cortical Development; Postoperative Care; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Seizures; Treatment Outcome | 2009 |
Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Brain Mapping; Case-Control Studies; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuroglia; Neurons; Neuropsychological Tests; Positron-Emission Tomography; Statistics as Topic | 2008 |
Pathophysiological mechanism of ipsilateral cerebral and brainstem hemiatrophy in basal ganglia germ cell tumors: case report.
Topics: Atrophy; Brain; Brain Neoplasms; Brain Stem; Cerebral Angiography; Cerebrum; Child; Fluorodeoxyglucose F18; Functional Laterality; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography | 2009 |
The neuropsychological and neuroradiological correlates of slowly progressive visual agnosia.
Topics: Agnosia; Aspartic Acid; Atrophy; Brain; Brain Mapping; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Middle Aged; Nerve Degeneration; Neuropsychological Tests; Occipital Lobe; Parietal Lobe; Positron-Emission Tomography; Temporal Lobe | 2009 |
A combined neuropsychological and brain imaging study of obstructive sleep apnea.
Topics: Ataxia; Atrophy; Attention; Blood Glucose; Brain; Cerebral Cortex; Cognition Disorders; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Polysomnography; Positron-Emission Tomography; Sleep Apnea, Obstructive | 2009 |
Occurrence of basal ganglia germ cell tumors without a mass.
Topics: Adolescent; Age Distribution; Age Factors; Antineoplastic Agents; Asian People; Atrophy; Basal Ganglia; Basal Ganglia Diseases; Brain Neoplasms; Brain Stem; Calcinosis; Child; Dementia; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Paresis; Positron-Emission Tomography; Radiotherapy | 2009 |
Posterior cingulate hypometabolism in early Alzheimer's disease: what is the contribution of local atrophy versus disconnection?
Topics: Alzheimer Disease; Atrophy; Biomarkers; Early Diagnosis; Energy Metabolism; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Neural Pathways; Positron-Emission Tomography; Predictive Value of Tests | 2009 |
Posterior cortical atrophy with [11C] Pittsburgh compound B accumulation in the primary visual cortex.
Topics: Aniline Compounds; Atrophy; Brain Mapping; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Hemianopsia; Humans; Magnetic Resonance Imaging; Middle Aged; Neurofibrillary Tangles; Plaque, Amyloid; Positron-Emission Tomography; Predictive Value of Tests; Thiazoles; Vision Disorders; Visual Cortex | 2010 |
Metabolic compensation and depression in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Atrophy; Brain; Brain Chemistry; Depression; Executive Function; Female; Fluorodeoxyglucose F18; Health Status; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Radiopharmaceuticals | 2010 |
Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2.
Topics: Adult; Atrophy; Brain; Brain Mapping; Cognition Disorders; Disease Progression; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myotonic Dystrophy; Nerve Fibers, Myelinated; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Young Adult | 2010 |
Teaching NeuroImages: FDG-PET in progressive supranuclear palsy.
Topics: Accidental Falls; Aged; Atrophy; Biomarkers; Brain; Deglutition Disorders; Diagnosis, Differential; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Mesencephalon; Ocular Motility Disorders; Personality Disorders; Positron-Emission Tomography; Predictive Value of Tests; Supranuclear Palsy, Progressive | 2010 |
Hemiparkinsonism and hemiatrophy syndrome: a rare observation.
Topics: Atrophy; Brain Chemistry; Dopamine Plasma Membrane Transport Proteins; Dystonia; Female; Fluorodeoxyglucose F18; Functional Laterality; Gait Disorders, Neurologic; Humans; Middle Aged; Muscle Weakness; Neurologic Examination; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2010 |
A mouse model characterizing features of vascular dementia with hippocampal atrophy.
Topics: Animals; Apoptosis; Atrophy; Behavior, Animal; Carotid Artery, Common; Carotid Stenosis; Cerebrovascular Circulation; Dementia, Vascular; Disease Models, Animal; Fluorodeoxyglucose F18; Hippocampus; Male; Maze Learning; Mice; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2010 |
Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images.
Topics: Aged; Alzheimer Disease; Aniline Compounds; Atrophy; Benzothiazoles; Brain Chemistry; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Likelihood Functions; Magnetic Resonance Imaging; Male; Middle Aged; Nitriles; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Temporal Lobe; Thiazoles | 2010 |
Attention-deficit/hyperactivity phenotype in mice lacking the cyclin-dependent kinase 5 cofactor p35.
Topics: Animals; Atrophy; Attention Deficit Disorder with Hyperactivity; Brain; Disease Models, Animal; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Fluorodeoxyglucose F18; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Neural Pathways; Phenotype; Phosphotransferases; Positron-Emission Tomography; Prefrontal Cortex; Receptors, AMPA; Serotonin; Synaptic Transmission | 2010 |
A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Biomarkers; Cerebrospinal Fluid; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; tau Proteins; Temporal Lobe; Tomography, Emission-Computed, Single-Photon | 2010 |
[(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia.
Topics: Aged; Aged, 80 and over; Aniline Compounds; Atrophy; Benzothiazoles; Cerebellum; Dementia; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2010 |
A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration.
Topics: Aged; Aging; Alzheimer Disease; Atrophy; Brain; Brain Mapping; Cerebrospinal Fluid Proteins; Cognitive Dysfunction; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Functional Laterality; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
Atrophy, hypometabolism and white matter abnormalities in semantic dementia tell a coherent story.
Topics: Aged; Atrophy; Brain Mapping; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Imaging, Three-Dimensional; Male; Metabolic Diseases; Middle Aged; Nerve Fibers, Myelinated; Neural Pathways; Neuropsychological Tests; Positron-Emission Tomography; Statistics, Nonparametric | 2011 |
"Reversible" Alzheimer's disease?
Topics: Aged; Alzheimer Disease; Atrophy; Cohort Studies; Combined Modality Therapy; Donepezil; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Indans; Life Style; Magnetic Resonance Imaging; Male; Mental Status Schedule; Motor Activity; Neuropsychological Tests; Nootropic Agents; Piperidines; Positron-Emission Tomography; Psychometrics; Remission, Spontaneous; Temporal Lobe | 2011 |
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy.
Topics: Aged; Alzheimer Disease; Arginine; Atrophy; Epilepsy; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Mutation; Positron-Emission Tomography; Presenilin-2; Temporal Lobe; Tomography, X-Ray Computed; Tryptophan | 2012 |
Clinical course of patients with familial early-onset Alzheimer's disease potentially lacking senile plaques bearing the E693Δ mutation in amyloid precursor protein.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Aniline Compounds; Apolipoproteins E; Atrophy; Benzothiazoles; Brain; Cerebellar Ataxia; Cognition; Disease Progression; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Magnetic Resonance Imaging; Memory Disorders; Middle Aged; Mutation; Neuropsychological Tests; Pedigree; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles | 2011 |
Posterior cingulate atrophy and metabolic decline in early stage Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Apolipoproteins E; Atrophy; Attention; Brain Mapping; Cognition; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Learning; Magnetic Resonance Imaging; Male; Mental Status Schedule; Metabolic Diseases; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography | 2012 |
Posterior cortical atrophy with prominent alexia without agraphia in a Tourette syndrome.
Topics: Aged; Alexia, Pure; Atrophy; Cerebral Cortex; Electroencephalography; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Tourette Syndrome | 2011 |
Deiodinase 2 expression is increased in dorsocervical fat of patients with HIV-associated lipohypertrophy syndrome.
Topics: Adipose Tissue, Brown; Adiposity; Atrophy; Back; Biopsy; Cohort Studies; Energy Metabolism; Fluorodeoxyglucose F18; Glucose; HIV-Associated Lipodystrophy Syndrome; Humans; Hypertrophy; Iodide Peroxidase; Iodothyronine Deiodinase Type II; Male; Middle Aged; Multimodal Imaging; Obesity, Abdominal; Positron-Emission Tomography; Subcutaneous Fat; Tissue Distribution; Tomography, X-Ray Computed; Up-Regulation | 2012 |
IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment.
Topics: Adrenal Cortex Hormones; Aged; Alzheimer Disease; Antibodies, Monoclonal, Murine-Derived; Atrophy; Autoimmunity; Biomarkers; Blotting, Western; Cognition Disorders; Cyclophosphamide; Disease Progression; Electrophysiology; Female; Fluorodeoxyglucose F18; Frontal Lobe; Hippocampus; Humans; Immunoglobulin A; Immunohistochemistry; Immunotherapy; Lewy Body Disease; Magnetic Resonance Imaging; Neurons; Plasma Exchange; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, N-Methyl-D-Aspartate; Rituximab; Synapses; Temporal Lobe; Treatment Outcome | 2012 |
Hypometabolism precedes limbic atrophy and spontaneous recurrent seizures in a rat model of TLE.
Topics: Analysis of Variance; Animals; Atrophy; Brain Mapping; CA1 Region, Hippocampal; Disease Models, Animal; Disease Progression; Electroencephalography; Electron Transport Complex IV; Epilepsy, Temporal Lobe; Excitatory Amino Acid Agonists; Fluorodeoxyglucose F18; Glial Fibrillary Acidic Protein; Glucose Metabolism Disorders; Glucose Transporter Type 1; Kainic Acid; Limbic System; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Pyramidal Cells; Rats; Rats, Wistar; Synaptophysin; Time Factors | 2012 |
Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.
Topics: Adult; Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Atrophy; Biomarkers; Carbon Radioisotopes; Cognition; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Neuropsychological Tests; Peptide Fragments; Presenilin-1; Radionuclide Imaging; Radiopharmaceuticals; tau Proteins; Thiazoles | 2012 |
Complex visual manifestations of posterior cortical atrophy.
Topics: Aged; Atrophy; Brain Diseases; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Retrospective Studies; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Vision Disorders | 2012 |
Striking asymmetry in cerebral metabolism in Dyke-Davidoff-Masson (DDM) syndrome: FDG-PET and MRI correlation.
Topics: Atrophy; Cerebrum; Child; Dilatation, Pathologic; Dominance, Cerebral; Energy Metabolism; Epilepsies, Myoclonic; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Intellectual Disability; Lateral Ventricles; Magnetic Resonance Imaging; Neck Muscles; Paresis; Positron-Emission Tomography; Skull; Statistics as Topic | 2013 |
Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD).
Topics: Adult; Aged; Atrophy; Brain; Cerebrovascular Circulation; Creutzfeldt-Jakob Syndrome; Down-Regulation; Electroencephalography; Energy Metabolism; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and
Topics: Alzheimer Disease; Atrophy; Corpus Callosum; Disease Progression; Electroencephalography; Fluorodeoxyglucose F18; Hippocampus; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Neocortex; Nerve Degeneration; Neurons; Radiography; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed | 2002 |
Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging.
Topics: Atrophy; Corpus Striatum; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mesencephalon; Middle Aged; Parkinson Disease; Putamen; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Neocortical temporal FDG-PET hypometabolism correlates with temporal lobe atrophy in hippocampal sclerosis associated with microscopic cortical dysplasia.
Topics: Adolescent; Adult; Atrophy; Blood Glucose; Brain Mapping; Cerebral Cortex; Diagnosis, Differential; Dominance, Cerebral; Energy Metabolism; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Mathematical Computing; Middle Aged; Psychosurgery; Reference Values; Sclerosis; Temporal Lobe; Tomography, Emission-Computed | 2003 |
Diagnostic imaging in 13 cases of Rasmussen's encephalitis: can early MRI suggest the diagnosis?
Topics: Atrophy; Brain; Child; Child, Preschool; Diagnosis, Differential; Disease Progression; Encephalitis; Female; Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Protons; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment.
Topics: Aged; Atrophy; Brain; Cognition Disorders; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory; Memory Disorders; Middle Aged; Prospective Studies; Radiopharmaceuticals; Statistics as Topic; Tomography, Emission-Computed | 2003 |
The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET.
Topics: Aged; Alzheimer Disease; Atrophy; Brain Mapping; Case-Control Studies; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Vision Disorders; Visual Perception | 2003 |
Neuro-ophthalmic findings in the visual variant of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Blindness, Cortical; Female; Fluorodeoxyglucose F18; Hemianopsia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Occipital Lobe; Parietal Lobe; Retrospective Studies; Tomography, Emission-Computed; Vision Disorders; Visual Field Tests; Visual Fields | 2004 |
Multimodal longitudinal imaging of focal status epilepticus.
Topics: Atrophy; Brain Mapping; Cerebral Cortex; Cerebrovascular Circulation; Child; Electroencephalography; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Magnetic Resonance Imaging; Status Epilepticus; Treatment Failure | 2004 |
Prefrontal atrophy in first episodes of schizophrenia associated with limbic metabolic hyperactivity.
Topics: Adult; Atrophy; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Limbic System; Male; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals; Schizophrenia | 2005 |
Separating functional and structural damage in persistent vegetative state using combined voxel-based analysis of 3-D MRI and FDG-PET.
Topics: Adult; Atrophy; Brain; Cerebrovascular Circulation; Energy Metabolism; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Hypoxia-Ischemia, Brain; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Persistent Vegetative State; Positron-Emission Tomography | 2005 |
Brain FDG PET study of normal aging in Japanese: effect of atrophy correction.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Atrophy; Brain; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Japan; Magnetic Resonance Imaging; Male; Middle Aged; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2005 |
Suffer the children: the psychobiology of early adversity.
Topics: Adult; Atrophy; Child; Cognitive Behavioral Therapy; Depression; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Hypothalamo-Hypophyseal System; Interpersonal Relations; Pituitary-Adrenal System; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Cerebral metabolic dysfunction and impaired vigilance in recently abstinent methamphetamine abusers.
Topics: Adult; Arousal; Atrophy; Brain; Brain Mapping; Central Nervous System Stimulants; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Hippocampus; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Methamphetamine; Neuropsychological Tests; Positron-Emission Tomography; Substance Withdrawal Syndrome; Substance-Related Disorders | 2005 |
Association between cognitive performance and cortical glucose metabolism in patients with mild Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Atrophy; Brain; Cerebral Cortex; Cognition; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography | 2005 |
Clinical insights into paraneoplastic cerebellar degeneration.
Topics: Adult; Ataxia; Atrophy; Biopsy; Bone Marrow; Breast Neoplasms; Carcinoma, Ductal; Cerebellar Neoplasms; Cerebellum; Diagnosis, Differential; Disease Progression; Dysarthria; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Migraine Disorders; Ovarian Cysts; Paraneoplastic Cerebellar Degeneration; Positron-Emission Tomography; Purkinje Cells; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
Effective treatment with levodopa and carbidopa for hypomyelination with atrophy of the basal ganglia and cerebellum.
Topics: Administration, Oral; Antiparkinson Agents; Atrophy; Basal Ganglia; Carbidopa; Cerebellum; Child, Preschool; Demyelinating Diseases; Diagnosis, Differential; Drug Therapy, Combination; Dystonia; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Spinocerebellar Degenerations; Treatment Outcome | 2006 |
18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease.
Topics: Adult; Aged; Aged, 80 and over; Atrophy; Celiac Disease; Duodenum; Female; Fluorodeoxyglucose F18; Humans; Intestinal Mucosa; Intestinal Neoplasms; Longitudinal Studies; Lymphatic Diseases; Lymphoma, T-Cell; Male; Middle Aged; Positron-Emission Tomography; Radiography, Abdominal; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2006 |
Abnormal configural face perception in a patient with right anterior temporal lobe atrophy.
Topics: Atrophy; Face; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Magnetic Resonance Imaging; Middle Aged; Neuropsychological Tests; Pattern Recognition, Visual; Perceptual Distortion; Photic Stimulation; Positron-Emission Tomography; Reaction Time; Severity of Illness Index; Temporal Lobe | 2006 |
Amygdala-prefrontal disconnection in borderline personality disorder.
Topics: Adult; Aggression; Amygdala; Atrophy; Borderline Personality Disorder; Emotions; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Impulsive Behavior; Male; Middle Aged; Neural Pathways; Piperazines; Positron-Emission Tomography; Predictive Value of Tests; Prefrontal Cortex; Serotonin Receptor Agonists | 2007 |
Adult-onset Rasmussen's encephalitis: anatomical-electrographic-clinical features of 7 Italian cases.
Topics: Adult; Age of Onset; Atrophy; Brain; Diagnosis, Differential; Electroencephalography; Electromyography; Encephalitis; Epilepsia Partialis Continua; Epilepsies, Partial; Evoked Potentials, Somatosensory; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Magnetic Resonance Imaging; Middle Aged; Phenotype; Positron-Emission Tomography; Retrospective Studies | 2006 |
Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.
Topics: Adolescent; Adult; Aged; Atrophy; Blood Glucose; Brain; Caudate Nucleus; Cerebral Cortex; Cerebral Ventricles; Child; Corpus Striatum; Dementia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Middle Aged; Putamen; Thalamus; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1982 |
Is interictal temporal hypometabolism related to mesial temporal sclerosis? A positron emission tomography/magnetic resonance imaging confrontation.
Topics: Adult; Atrophy; Deoxyglucose; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Sclerosis; Temporal Lobe; Tomography, Emission-Computed | 1995 |
New Spielmeyer-Vogt variant with granular inclusions and early brain atrophy.
Topics: Adult; Atrophy; Brain; Child; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Genetic Variation; Humans; Inclusion Bodies; Learning Disabilities; Neuronal Ceroid-Lipofuscinoses; Nuclear Family; Tomography, Emission-Computed; Vision Disorders | 1995 |
Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
Topics: Atrophy; Brain Diseases; Corpus Striatum; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Male; Middle Aged; Olivopontocerebellar Atrophies; Parkinson Disease; Substantia Nigra; Tomography, Emission-Computed | 1995 |
Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome.
Topics: Adult; Atrophy; Brain; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Syndrome; Tomography, Emission-Computed | 1994 |
Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Atrophy; Brain; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, Emission-Computed | 1993 |
Functional importance of ventricular enlargement and cortical atrophy in healthy subjects and alcoholics as assessed with PET, MR imaging, and neuropsychologic testing.
Topics: Adult; Alcoholism; Atrophy; Brain; Cerebral Cortex; Cerebral Ventricles; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Reference Values; Tomography, Emission-Computed | 1993 |
Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome.
Topics: Adult; Aged; Atrophy; Blood Glucose; Brain; Deoxyglucose; Dominance, Cerebral; Energy Metabolism; Facial Hemiatrophy; Female; Fluorodeoxyglucose F18; Hemiplegia; Humans; Middle Aged; Neurologic Examination; Parkinson Disease; Tomography, Emission-Computed | 1993 |
Neuropsychological deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients.
Topics: Adult; Aged; Alcoholism; Atrophy; Blood Glucose; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Frontal Lobe; Gyrus Cinguli; Humans; Intelligence; Male; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed; Veterans; Wechsler Scales | 1993 |
PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration.
Topics: Aged; Apraxias; Atrophy; Basal Ganglia; Basal Ganglia Diseases; Brain Diseases; Cerebral Cortex; Cerebrovascular Circulation; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Nerve Degeneration; Tomography, Emission-Computed | 1996 |
Hippocampal atrophy is not a major determinant of regional hypometabolism in temporal lobe epilepsy.
Topics: Adult; Atrophy; Basal Ganglia; Brain; Deoxyglucose; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Temporal Lobe; Thalamus; Tomography, Emission-Computed | 1997 |
Discordance between traditional pathologic and energy metabolic changes in very early Alzheimer's disease. Pathophysiological implications.
Topics: Acetylcholinesterase; Alzheimer Disease; Atrophy; Brain; Cerebellum; Cerebral Cortex; Energy Metabolism; Fluorodeoxyglucose F18; Glucose; Humans; Longitudinal Studies; Neurofibrillary Tangles; Neuroglia; Neurons; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed | 1999 |
Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations.
Topics: Aged; Aged, 80 and over; Atrophy; Basal Ganglia; Base Sequence; Brain; Child; Chromosomes, Human, Pair 17; Dinucleotide Repeats; Exons; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Neurofibrillary Tangles; Pedigree; Phenotype; Polymorphism, Genetic; Radiopharmaceuticals; Supranuclear Palsy, Progressive; tau Proteins; Tomography, Emission-Computed | 2000 |
Accurate prediction of postoperative outcome in mesial temporal lobe epilepsy: a study using positron emission tomography with 18fluorodeoxyglucose.
Topics: Adult; Atrophy; Discriminant Analysis; Electroencephalography; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Temporal Lobe; Tomography, Emission-Computed; Treatment Outcome | 2000 |
Combined semantic dementia and apraxia in a patient with frontotemporal lobar degeneration.
Topics: Anomia; Apraxias; Atrophy; Dementia; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Middle Aged; Neuropsychological Tests; Pick Disease of the Brain; Semantics; Temporal Lobe; Tomography, Emission-Computed | 2000 |
Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
Topics: Aged; Alzheimer Disease; Atrophy; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Reference Values; Software Validation; Tomography, Emission-Computed | 2001 |
(18)F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis.
Topics: Adolescent; Adult; Atrophy; Biopsy; Blood Glucose; Brain; Child; Child, Preschool; Disease Progression; Dominance, Cerebral; Encephalitis; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Male; Retrospective Studies; Tomography, Emission-Computed | 2001 |
In vivo hippocampal glucose metabolism in mesial temporal lobe epilepsy.
Topics: Adolescent; Adult; Atrophy; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Frontotemporal dementia: a clinical-pathological study.
Topics: Adult; Aphasia; Atrophy; Cell Count; Dementia; Fatal Outcome; Female; Fluorodeoxyglucose F18; Frontal Lobe; Gliosis; Humans; Mental Disorders; Neurons; Personality Disorders; tau Proteins; Temporal Lobe; Tomography, Emission-Computed; Ubiquitin | 2001 |
Hemi-parkinsonism in multiple system atrophy: a PET and MRI study.
Topics: Adult; Aged; Atrophy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organ Specificity; Parkinson Disease; Reference Values; Tomography, Emission-Computed | 1992 |
Slowly progressive aphasia: three cases with language, memory, CT and PET data.
Topics: Aged; Aphasia; Atrophy; Blood Glucose; Brain; Brain Mapping; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Male; Mental Recall; Middle Aged; Neuropsychological Tests; Psychomotor Performance; Retention, Psychology; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1990 |
Computed tomography, magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in multiple system atrophy and pure autonomic failure.
Topics: Atrophy; Autonomic Nervous System Diseases; Brain; Brain Stem; Cerebellum; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Putamen; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1991 |
The Marinesco-Sjögren syndrome examined by computed tomography, magnetic resonance, and 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography.
Topics: Adult; Atrophy; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Spinocerebellar Degenerations; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1990 |
[Positron emission tomography and evoked potentials in the early detection of hereditary ataxias].
Topics: Atrophy; Blood Glucose; Cerebellum; Deoxyglucose; Electroencephalography; Evoked Potentials; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Spinocerebellar Degenerations; Tomography, Emission-Computed | 1989 |
Positron emission tomography in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Atrophy; Dementia; Deoxyglucose; Electroencephalography; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Occipital Lobe; Parietal Lobe; Psychiatric Status Rating Scales; Psychological Tests; Rest; Temporal Lobe; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1986 |
Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Brain; Deoxyglucose; Fluorodeoxyglucose F18; Gliosis; Humans; Magnetic Resonance Spectroscopy; Male; Neurofibrils; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1986 |
Positron emission tomography in aging and dementia: effect of cerebral atrophy.
Topics: Aged; Aged, 80 and over; Aging; Atrophy; Brain; Dementia; Deoxyglucose; Diagnostic Errors; Fluorine; Fluorodeoxyglucose F18; Humans; Middle Aged; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1987 |
Relation of measured brain glucose utilisation and cerebral atrophy in man.
Topics: Adult; Aged; Aged, 80 and over; Aging; Atrophy; Brain; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Tomography, Emission-Computed | 1987 |
Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression.
Topics: Adult; Age Factors; Aged; Atrophy; Brain; Cerebral Ventricles; Chronic Disease; Deoxyglucose; Depressive Disorder; Fluorine; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Middle Aged; Radioisotopes; Schizophrenia; Tomography, X-Ray Computed | 1986 |